In the group of families with no ovarian cancer but at least two or more breast cancer cases with only one of them diagnosed before the age of 50 (Group C), the mutation detection rate for BRCA1 was 11% and for BRCA2 8% or 19% for both genes. Here, BRCA2 is linked to ovarian cancer.